Investing.com - Baxter (NYSE:BAX) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Baxter announced earnings per share of $0.8 on revenue of $3.10B. Analysts polled by Investing.com anticipated EPS of $0.7483 on revenue of $3.11B.
Baxter shares are up 19% from the beginning of the year and are trading at $81.91 , down-from-52-week-high.They are under-performing the AEX which is up 21% from the start of the year.
Baxter follows other major Healthcare sector earnings this month
Baxter's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar